Lecigon development status

Lecigon development status 2018-10-08T15:21:02+00:00

Sweden and EU

  • Lobsor´ s near-term focus is to obtain market authorization in the Nordic countries and key markets in Europe.
  • Lecigon®, has been granted marketing authorization by the Swedish Medical Agency by Oct 5th 2018. Process of obtaining pricing and reimbursement approval in Sweden is ongoing.

US and Canada

  • A newly formed US based company, Intrance Medical Systems Inc. is responsible for development and commercialization of Lecigon in the US and Canada.